ELV * Stock Overview Operates as a health benefits company in the United States. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Elevance Health, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Elevance Health Historical stock prices Current Share Price US$7,700.00 52 Week High US$11,202.00 52 Week Low US$7,689.45 Beta 0.83 1 Month Change -4.75% 3 Month Change -24.84% 1 Year Change n/a 3 Year Change -17.58% 5 Year Change 35.71% Change since IPO 837.20%
Recent News & Updates
Insufficient new directors Dec 11
Upcoming dividend of US$1.63 per share Nov 28
Third quarter dividend of US$1.63 announced Oct 20
Elevance Health, Inc. (NYSE:ELV) agreed to acquire CareBridge Medical Group, P.C. Oct 18
Third quarter 2024 earnings released: EPS: US$4.36 (vs US$5.48 in 3Q 2023) Oct 17 Elevance Health, Inc. Declares Dividend for the Fourth Quarter of 2024, Payable on December 20, 2024 See more updates
Insufficient new directors Dec 11
Upcoming dividend of US$1.63 per share Nov 28
Third quarter dividend of US$1.63 announced Oct 20
Elevance Health, Inc. (NYSE:ELV) agreed to acquire CareBridge Medical Group, P.C. Oct 18
Third quarter 2024 earnings released: EPS: US$4.36 (vs US$5.48 in 3Q 2023) Oct 17 Elevance Health, Inc. Declares Dividend for the Fourth Quarter of 2024, Payable on December 20, 2024
Las Mercedes Medical Centers acquired Pasteur and Wellmax Medical Centers from Elevance Health, Inc. (NYSE:ELV). Oct 08
Elevance Health, Inc. to Report Q3, 2024 Results on Oct 17, 2024 Oct 07
Upcoming dividend of US$1.63 per share Sep 03
Clayton, Dubilier & Rice and Elevance Health Announces the Introduction of Mosaic Health, a National Care Delivery Platform Aug 14
Independent Director recently sold Mex$2.8m worth of stock Jul 23
Second quarter dividend of US$1.63 announced Jul 22
Elevance Health, Inc. Declares Dividend for the Third Quarter of 2024, Payable on September 25, 2024 Jul 17
Elevance Health, Inc. to Report Q2, 2024 Results on Jul 17, 2024 Jun 27
Insufficient new directors Jun 25
Upcoming dividend of US$1.63 per share Jun 03
Insufficient new directors May 09
Insider recently sold Mex$117m worth of stock Apr 28
First quarter dividend of US$1.63 announced Apr 23 Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024
Insufficient new directors Apr 18
Elevance Health, Inc. to Report Q1, 2024 Results on Apr 18, 2024 Apr 04
StanCorp Financial Group, Inc. completed the acquisition of Life & Disability business of Elevance Health, Inc. Apr 03
StanCorp Financial Group, Inc. completed the acquisition of Life & Disability business of Elevance Health, Inc. Apr 02
Senior VP recently sold Mex$7.8m worth of stock Mar 11
Insufficient new directors Mar 06
Upcoming dividend of US$1.63 per share Feb 29
Full year 2023 earnings released: EPS: US$25.38 (vs US$24.56 in FY 2022) Feb 23
Elevance Health, Inc., Annual General Meeting, May 15, 2024 Feb 19
Insufficient new directors Feb 16
Elevance Health, Inc. Declares Quarterly Cash Dividend, Payable on March 22, 2024 Jan 26
Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024 Jan 24
Elevance Health, Inc. to Report Q4, 2023 Results on Jan 24, 2024 Jan 11
Elevance Health Addresses Healthcare’S Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services Jan 10
Senior VP recently sold Mex$8.7m worth of stock Dec 05
Insufficient new directors Dec 05
Third quarter 2023 earnings released: EPS: US$5.48 (vs US$6.75 in 3Q 2022) Oct 20 Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023
Elevance Health, Inc. to Report Q3, 2023 Results on Oct 18, 2023 Oct 05
Insufficient new directors Oct 04
Upcoming dividend of US$1.48 per share at 1.3% yield Aug 31
Insufficient new directors Aug 18 Elevance Health, Inc. Announces Executive Changes
Independent Director recently sold Mex$2.5m worth of stock Jul 24 Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023
Second quarter 2023 earnings released: EPS: US$7.79 (vs US$6.87 in 2Q 2022) Jul 20
Elevance Health, Inc. to Report Q2, 2023 Results on Jul 19, 2023 Jun 29
Upcoming dividend of US$1.48 per share at 1.3% yield Jun 01
First quarter 2023 earnings released: EPS: US$8.30 (vs US$7.48 in 1Q 2022) Apr 20
Insufficient new directors Mar 17
Upcoming dividend of US$1.48 per share at 1.3% yield Mar 02
Elevance Health, Inc., Annual General Meeting, May 10, 2023 Feb 18
Elevance Health Inc. (NYSE:ELV) completed the acquisition of BioPlus Specialty Pharmacy Services, LLC from CarepathRx. Feb 16
Full year 2022 earnings released: EPS: US$24.82 (vs US$25.04 in FY 2021) Jan 27 Elevance Health Inc. Provides Earnings Guidance for the Fiscal Year 2023
Elevance Health Inc. (NYSE:ELV) entered into a definitive agreement Louisiana Health Service and Indemnity Company. Jan 24
Elevance Health Inc. to Report Q4, 2022 Results on Jan 25, 2023 Jan 12
Insufficient new directors Jan 10
Insufficient new directors Dec 05
Upcoming dividend of US$1.28 per share Nov 25
Insufficient new directors Nov 16
Elevance Health Inc. (NYSE:ELV) entered into an agreement to acquire BioPlus Specialty Pharmacy Services, LLC from CarepathRx. Nov 10
Elevance Health, Inc. Appoints Deanna Strable-Soethout as an Independent Director, Effective November 1, 2022 Oct 26
Elevance Health Inc. Provides Earnings Guidance for Full Year 2022 Oct 20
Elevance Health Inc. to Report Q3, 2022 Results on Oct 19, 2022 Oct 06
Insufficient new directors Sep 22
Insufficient new directors Sep 02
Insufficient new directors Aug 12
Second quarter 2022 earnings released Jul 21 Elevance Health Inc. Declares Third Quarter 2022 Dividend, Payable on September 23, 2022
Elevance Health Inc. to Report Q2, 2022 Results on Jul 20, 2022 Jul 07
Insufficient new directors Jun 22
Independent Director recently sold Mex$4.1m worth of stock Jun 09
Upcoming dividend of US$1.28 per share Jun 02
Anthem, Inc. (NYSE:ANTM) completed the acquisition of Integra MLTC, Inc. from Personal-Touch Home Care, Inc. May 06
Insufficient new directors May 05
Anthem, Inc. Provides Earnings Guidance for the Year 2022 Apr 24
Anthem, Inc. Declares Second Quarter 2022 Dividend, Payable on June 24, 2022 Apr 21
Anthem, Inc. to Report Q1, 2022 Results on Apr 20, 2022 Apr 07
Senior VP recently sold Mex$8.3m worth of stock Mar 12
Upcoming dividend of US$1.28 per share Mar 02
Anthem, Inc., Annual General Meeting, May 18, 2022 Feb 19
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Jan 28
Anthem, Inc. Provides Earnings Guidance for the Full Year of 2022 Jan 27 Shareholder Returns ELV * MX Healthcare MX Market 7D 0% 1.5% -2.4% 1Y n/a -31.2% -14.9%
See full shareholder returns
Return vs Market: Insufficient data to determine how ELV * performed against the MX Market .
Price Volatility Is ELV *'s price volatile compared to industry and market? ELV * volatility ELV * Average Weekly Movement n/a Healthcare Industry Average Movement 6.4% Market Average Movement 4.1% 10% most volatile stocks in MX Market 6.0% 10% least volatile stocks in MX Market 2.7%
Stable Share Price: ELV *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine ELV *'s volatility change over the past year.
About the Company Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Show more Elevance Health, Inc. Fundamentals Summary How do Elevance Health's earnings and revenue compare to its market cap? ELV * fundamental statistics Market cap Mex$1.74t Earnings (TTM ) Mex$129.41b Revenue (TTM ) Mex$3.51t
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) ELV * income statement (TTM ) Revenue US$174.02b Cost of Revenue US$125.40b Gross Profit US$48.61b Other Expenses US$42.20b Earnings US$6.42b
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 27.67 Gross Margin 27.94% Net Profit Margin 3.69% Debt/Equity Ratio 61.9%
How did ELV * perform over the long term?
See historical performance and comparison Dividends
1.7% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/25 16:09 End of Day Share Price 2024/12/18 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Elevance Health, Inc. is covered by 51 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Jasper Hellweg Argus Research Company Hua Ha Baird Ishan Majumdar Baptista Research
Show 48 more analysts 
